hVIVO plc
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker an… Read more
hVIVO plc (HVO) - Total Assets
Latest total assets as of June 2025: GBX85.67 Million GBX
Based on the latest financial reports, hVIVO plc (HVO) holds total assets worth GBX85.67 Million GBX as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
hVIVO plc - Total Assets Trend (2011–2024)
This chart illustrates how hVIVO plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
hVIVO plc - Asset Composition Analysis
Current Asset Composition (December 2024)
hVIVO plc's total assets of GBX85.67 Million consist of 67.8% current assets and 32.3% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 49.7% |
| Accounts Receivable | GBX13.96 Million | 15.7% |
| Inventory | GBX804.00K | 0.9% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX101.00K | 0.1% |
| Goodwill | GBX5.60 Million | 6.3% |
Asset Composition Trend (2011–2024)
This chart illustrates how hVIVO plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: hVIVO plc's current assets represent 67.8% of total assets in 2024, an increase from 55.6% in 2011.
- Cash Position: Cash and equivalents constituted 49.7% of total assets in 2024, up from 5.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 15.7% of total assets.
hVIVO plc Competitors by Total Assets
Key competitors of hVIVO plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
hVIVO plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - hVIVO plc generates 0.71x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, hVIVO plc generates $ 11.98 in net profit.
hVIVO plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.60 | 1.61 | 2.72 |
| Quick Ratio | 1.53 | 1.60 | 2.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX15.86 Million | GBX 21.80 Million | GBX 11.54 Million |
hVIVO plc - Advanced Valuation Insights
This section examines the relationship between hVIVO plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.98 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.8% |
| Total Assets | GBX88.89 Million |
| Market Capitalization | $5.18K USD |
Valuation Analysis
Below Book Valuation: The market values hVIVO plc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: hVIVO plc's assets grew by 6.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for hVIVO plc (2011–2024)
The table below shows the annual total assets of hVIVO plc from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX88.89 Million | +6.81% |
| 2023-12-31 | GBX83.23 Million | +61.99% |
| 2022-12-31 | GBX51.38 Million | +21.54% |
| 2021-12-31 | GBX42.27 Million | -12.92% |
| 2020-12-31 | GBX48.55 Million | +434.70% |
| 2019-12-31 | GBX9.08 Million | +16.32% |
| 2018-12-31 | GBX7.81 Million | -28.01% |
| 2017-12-31 | GBX10.84 Million | -13.56% |
| 2016-12-31 | GBX12.54 Million | +11.59% |
| 2015-12-31 | GBX11.24 Million | +140.57% |
| 2014-12-31 | GBX4.67 Million | +135.21% |
| 2013-12-31 | GBX1.99 Million | -44.80% |
| 2012-12-31 | GBX3.60 Million | +106.64% |
| 2011-12-31 | GBX1.74 Million | -- |